Bleeding scale and bleeding complication of the antithromboticf therapy in cardiological patients

Abstract

Antithrombotic drugs are the cornerstone of the cardiovascular medicine. Bleeding is certainly the hottest problem of the chronic antithormbotic therapy.

Contemporary bleeding scales do not assess bleeding complications of anticoagulation and/or antiaggregation therapy, because they were promarily designed for trombolysis in patients with myocardial infarction. The new bleeding score proposal was developed to focus on chronic antithrombotic therapy and their complications.

The recent data from many registers shows incorrenct dosage of antithrombotic therapy and define risc factors of bleeding.

Keywords

• antithrombotic therapy
• bleeding scales
• risc factors of bleeding